Altered Metabolic Responses to Intermittent Hypoxia in Mice with Partial Deficiency of Hypoxia-inducible Factor-1alpha
Overview
Molecular Biology
Authors
Affiliations
We have previously shown that exposure of C57BL/6J mice to intermittent hypoxia (IH) leads to 1) hypertriglyceridemia due to upregulation of pathways of lipid biosynthesis, including sterol regulatory element binding protein (SREBP)-1 and stearoyl CoA desaturase (SCD)-1; and 2) hypercholesterolemia due to impaired cholesterol uptake. The goal of the present study was to examine whether hypoxia-inducible factor (HIF)-1 is implicated in changes in lipid metabolism induced by IH. Lean HIF-1alpha (Hif1a)(+/-) mice, which are heterozygous for a null allele at the locus encoding the HIF-1alpha subunit, and their wild-type (WT) Hif1a(+/+) littermates were exposed to IH or control conditions for 5 days. IH increased fasting blood glucose, serum total cholesterol, and high-density lipoprotein-cholesterol, phospholipids, triglycerides (TG), and leptin in mice of both genotypes, whereas serum insulin and interleukin-6 were elevated only in WT mice. The impact of IH on serum TG levels in WT mice was significantly greater than that in Hif1a(+/-) mice (95 +/- 9 vs. 66 +/- 6 mg/dl, P < 0.05), whereas cholesterol and glucose levels were affected independently of genotype. Under hypoxic conditions, mRNA and protein levels of SREBP cleavage-activating protein (SCAP) and SCD-1 and protein levels of nuclear isoform of SREBP-1 in the liver were induced to significantly higher levels in WT mice than in Hif1a(+/-) mice. We conclude that 1) the effect of IH on serum TG levels is mediated through HIF-1, 2) HIF-1 may impact on posttranscriptional regulation of SREBP-1, and 3) the effect of IH on serum cholesterol levels was not altered by partial HIF-1alpha deficiency.
Flores K, Almeida C, Arriaza K, Pena E, El Alam S Int J Mol Sci. 2024; 25(20).
PMID: 39456805 PMC: 11508063. DOI: 10.3390/ijms252011023.
Lipid saturation controls nuclear envelope function.
Romanauska A, Kohler A Nat Cell Biol. 2023; 25(9):1290-1302.
PMID: 37591950 PMC: 10495262. DOI: 10.1038/s41556-023-01207-8.
Koritala B, Gaspar L, Bhadri S, Massie K, Lee Y, Paulose J Laryngoscope. 2023; 134 Suppl 4:S1-S11.
PMID: 37540033 PMC: 10838350. DOI: 10.1002/lary.30915.
Hrabalova P, Bohuslavova R, Matejkova K, Papousek F, Sedmera D, Abaffy P Cardiovasc Diabetol. 2023; 22(1):88.
PMID: 37072781 PMC: 10114478. DOI: 10.1186/s12933-023-01824-5.
Alterki A, Abu-Farha M, Al Shawaf E, Al-Mulla F, Abubaker J Int J Mol Sci. 2023; 24(7).
PMID: 37047780 PMC: 10095553. DOI: 10.3390/ijms24076807.